Reading Room Production — page 486

your interest in translational research on a broader scale including the CTSAs , particularly in light of the Cures Acceleration Network Initiative. The reason that I want to brief you is that Heidi is starting now to push OMB for real, new money for all these initiatives and this could be an opportunity for us to put some flesh on the whole Translational Research approach. I propose having a meeting at the end of next week (your office said that this was the best for your schedule) in which I together with my program person, Mike Kurilla, brief you on the entire MCM initiative as well as the role that they propose NIAID/NIH play. In addition, I can fill you in on the interesting dynamics between the White House and HHS. Best regards, Tony Anthony S. Fauci, MD Director National Institute of Allergy and Infectious Diseases vs onal = . al Bethesda, MD jis e-mail and any of its attachments is confidential and may contain sensitive information. It should not be used by anyone who is not the original intended recipient. If you have received this e-mail in error please inform the sender and delete it from your mailbox or any other storage devices. The National Institute of Allergy and Infectious Diseases (NIAID) shall not accept liability for any statements made that are the sender's own and not expressly made on behalf of the NIAID by one of its representatives.